TZIELD Registry
- Study HIC#:2000037535
- Last Updated:02/05/2026
The purpose of this study is to collect general information on patients with Stage 2 - Type 1 Diabetes and further information on the long-term effects of TZIELD in patients with Stage 2 Type 1 Diabetes, treated with TZIELD.
Contact Us
For more information about this study, including how to volunteer, contact:
Michele Alguard
- Phone Number: 1-203-764-6649
Help Us Discover!
You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call +18779788343 for more information.
Trial Purpose and Description
This is an observational study of patients with Stage 2 T1D treated with TZIELD in a post-marketing setting as per standard of care. A comparator group of unexposed patients with Stage 2 T1D will also be evaluated. Patients will be treated according to normal clinical practice, with no protocol-mandated visits, treatments, or examinations.
Eligibility Criteria
Participants diagnosed with Stage 2 Type 1 Diabetes who plan to initiate TZIELD treatment according to the currently approved label or who have initiated TZIELD treatment within 6 months prior to enrollment.
